Harpoon Therapeutics Inc (DELISTED) (HARP:DL)
23.01
0.00 (0.00%)
USD |
NASDAQ |
Mar 11, 16:00
Harpoon Therapeutics Shareholders Equity (Quarterly): 4.541M for Sept. 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 4.541M |
| June 30, 2023 | 2.998M |
| March 31, 2023 | 0.715M |
| December 31, 2022 | 5.399M |
| September 30, 2022 | 16.91M |
| June 30, 2022 | 26.64M |
| March 31, 2022 | 41.38M |
| December 31, 2021 | 58.07M |
| September 30, 2021 | 76.97M |
| June 30, 2021 | 90.93M |
| March 31, 2021 | 102.38M |
| Date | Value |
|---|---|
| December 31, 2020 | 53.84M |
| September 30, 2020 | 60.74M |
| June 30, 2020 | 71.91M |
| March 31, 2020 | 83.29M |
| December 31, 2019 | 94.22M |
| September 30, 2019 | 107.23M |
| June 30, 2019 | 122.47M |
| March 31, 2019 | 133.59M |
| December 31, 2018 | -53.48M |
| September 30, 2018 | -43.98M |
| December 31, 2017 | -26.94M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
0.715M
Minimum
Mar 2023
122.47M
Maximum
Jun 2019
56.70M
Average
59.41M
Median
Shareholders Equity (Quarterly) Benchmarks
| Merck & Co Inc | 40.36B |
| Axonics Inc | 627.10M |
| Johnson & Johnson | 70.02B |
| Boston Scientific Corp | 19.92B |
| Ambrx Biopharma Inc (DELISTED) | 242.40M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 47.58M |
| Total Liabilities (Quarterly) | 43.04M |
| Current Ratio | 1.894 |